%0 Journal Article
%T Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer
%A Alexa B. Schrock
%A Andrew Rankin
%A Axel Grothey
%A James X. Sun
%A Jeeyun Lee
%A Jeffrey S. Ross
%A Marwan Fakih
%A Philip J. Stephens
%A Rachel Erlich
%A Samuel J. Klempner
%A Siraj M. Ali
%A Thomas J. George
%A Jr.
%A Vincent A. Miller
%J Archive of "The Oncologist".
%D 2016
%R 10.1634/theoncologist.2016-0148
%K KRAS
%K Colon cancer
%K Biomarker
%K Genomic profiling
%K Epidermal growth factor receptor
%K Cetuximab
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189622/